The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial
出版年份 2016 全文链接
标题
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial
作者
关键词
-
出版物
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Volume 31, Issue 2, Pages 103-112
出版商
Wiley
发表日期
2016-02-09
DOI
10.1002/hup.2517
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
- (2015) Atefeh Zeinoddini et al. DEPRESSION AND ANXIETY
- Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial
- (2015) Seyed Hesameddin Abbasi et al. JOURNAL OF AFFECTIVE DISORDERS
- Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial
- (2015) Amirhossein Gougol et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism
- (2015) Ali Ghaleiha et al. PSYCHIATRY RESEARCH
- Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: A randomized, double-blind, placebo-controlled, clinical trial
- (2014) Seyed Mohammad Reza Hosseini et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study
- (2014) Mohammad-Reza Khodaie-Ardakani et al. PSYCHIATRY RESEARCH
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- Inflammation and schizophrenia
- (2013) AK Al-Asmari et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
- (2013) Mehdi Farokhnia et al. PSYCHOPHARMACOLOGY
- Schizophrenia and the immune system: Pathophysiology, prevention, and treatment
- (2012) M. D. Richard et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Cortical interneurons, immune factors and oxidative stress as early targets for schizophrenia
- (2012) Patricio O’Donnell EUROPEAN JOURNAL OF NEUROSCIENCE
- The Peroxisome Proliferator-activated Receptor γ (PPARγ) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis
- (2012) Valeria Benedusi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
- (2012) S Miyamoto et al. MOLECULAR PSYCHIATRY
- Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial
- (2012) Khatereh Sepanjnia et al. NEUROPSYCHOPHARMACOLOGY
- Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression
- (2012) Ladan Kashani et al. PSYCHONEUROENDOCRINOLOGY
- Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: A randomized double-blind study
- (2012) Robert C. Smith et al. SCHIZOPHRENIA RESEARCH
- Type-2 diabetes mellitus in schizophrenia: Increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up
- (2011) D. Schoepf et al. EUROPEAN PSYCHIATRY
- The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia
- (2011) Isabel Martínez-Gras et al. SCHIZOPHRENIA RESEARCH
- Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study
- (2010) Veronika Vlckova et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
- (2010) Norbert Müller et al. SCHIZOPHRENIA RESEARCH
- Stress-induced neuroinflammation: mechanisms and new pharmacological targets
- (2009) C.D. Munhoz et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients
- (2009) Monia Raffa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents
- (2008) Amy Hyong et al. BRAIN RESEARCH
- Negative symptoms in schizophrenia—A review
- (2008) J Mäkinen et al. NORDIC JOURNAL OF PSYCHIATRY
- Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
- (2007) Stéphane Potvin et al. BIOLOGICAL PSYCHIATRY
- Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
- (2007) Ramya Kapadia Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started